Skip to main content

Published locations for Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer

User login

  • Reset your password
  • /content/bevacizumab-halves-progression-risk-recurrent-ovarian-cancer
  • /internalmedicinenews/article/35463/oncology/bevacizumab-halves-progression-risk-recurrent-ovarian
  • /oncologypractice/article/35463/oncology/bevacizumab-halves-progression-risk-recurrent-ovarian-cancer
  • /hematology-oncology/article/35463/oncology/bevacizumab-halves-progression-risk-recurrent-ovarian
  • /internalmedicine/article/35463/oncology/bevacizumab-halves-progression-risk-recurrent-ovarian-cancer